Document Detail


Charcot neuroarthropathy: An often overlooked complication of diabetes.
MedLine Citation:
PMID:  20810870     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In patients with long-standing, poorly controlled diabetes and peripheral neuropathy, a red, hot, swollen foot without open ulceration should raise the suspicion of Charcot neuroarthropathy, an often-overlooked diabetic foot complication. The authors discuss key diagnostic features and how to differentiate this condition from cellulitis, osteomyelitis, and other conditions. They review key elements of the workup and emphasize the importance of early diagnosis and prompt treatment to preserve a functioning foot.
Authors:
Georgeanne Botek; Martha A Anderson; Ryan Taylor
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  77     ISSN:  1939-2869     ISO Abbreviation:  Cleve Clin J Med     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-02     Completed Date:  2010-12-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  593-9     Citation Subset:  IM    
Affiliation:
Diabetic Foot Center, Department of Orthopaedic Surgery, Orthopaedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH 44195, USA. botekg@ccf.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthropathy, Neurogenic / diagnosis*,  etiology,  physiopathology,  therapy
Diabetes Complications / physiopathology*
Diabetes Mellitus / physiopathology*
Diabetic Neuropathies / diagnosis*,  physiopathology
Diagnosis, Differential
Foot Diseases / diagnosis*,  etiology,  physiopathology,  therapy
Humans
Male
Middle Aged

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distal biceps tendon injuries.
Next Document:  Interferon-gamma-release assays: Better than tuberculin skin testing?